Free press releases distribution network?

Agency / Source: STEMCELL Technologies, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



STEMCELL Technologies Publishes Critical Points for Feeder-independent Cultures in mTeSR™1 or TeSR™2 - STEMCELL Technologies offers mTeSR™1 (defined) and TeSR™2 (animal protein-free and defined) maintenance medium for feeder-independent cultures of embryonic stem (ES) and induced pluripotent stem (iPS) cells - Stemcell.com
STEMCELL Technologies Publishes Critical Points for Feeder-independent Cultures in mTeSR™1 or TeSR™2

 

PRZOOM - /newswire/ - Vancouver, British Columbia, Canada, 2013/08/26 - STEMCELL Technologies offers mTeSR™1 (defined) and TeSR™2 (animal protein-free and defined) maintenance medium for feeder-independent cultures of embryonic stem (ES) and induced pluripotent stem (iPS) cells - Stemcell.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Some of the critical aspects of maintaining healthy ES and iPS cell cultures are outlined in the points below.

1. Appropriate matrix
Using the right matrix is critical to successful feeder-free cultures of ES and iPS cells in mTeSR™1 and TeSR™2. We recommend BD Matrigel™ hESC-qualified Matrix (BD, Catalog #354277) or Vitronectin XF™ (Catalog #07190) for mTeSR™1 cultures, and StemAdhere™ Defined Matrix for PSC (Catalog #07160) for TeSR™2 cultures. Always follow the supplier’s instructions when storing, diluting, and coating the plates with the matrices. Cells will fail to attach if plates are not coated appropriately with the right matrices. For information on how to coat plates properly with Matrigel™, please refer to our technical tip here.

2. Timing between successive passages
Using the same size and density of seeded aggregates, cells cultured in TeSR™2 grow slightly faster than those grown in mTeSR™1. Therefore mTeSR™1 cultures are usually passaged every 5-7 days, whereas TeSR™2 cultures are passaged every 4-6 days (dependent on the cell line). There is an approximate 24 hour window that is optimal for passaging cells grown in mTeSR™1 or TeSR™2. Cultures should be passaged when there are large colonies, with dense centers, and the colonies are just beginning to merge (i.e. plate is approximately 60 - 75% confluent).

3. Removing areas of differentiation
Before passaging, areas of differentiation should be selectively removed by scraping or aspirating off. If not removed, the differentiated cells will overgrow, and dominate subsequent cultures. Healthy cultures should have less than 20% differentiated areas.

4. Enzymatic or non-enzymatic passaging
For enzymatic passaging, Dispase (Catalog #07923) at 1 mg/mL is recommended to passage cells in mTeSR™1 and TeSR™2 cultures. Cells grown in TeSR™2 are slightly more sensitive to dispase than those grown in mTeSR™1, therefore the incubation period should be decreased to 3 - 4 minutes, from 5-7 min for mTeSR™1 cultures (incubation times are based on using dispase from STEMCELL Technologies; may require optimization, as there are differences in enzyme activity from different suppliers). Ensure that dispase is washed off, as residual dispase will continue to cleave the cell surface proteins that are required for the reattachment of cells to the new plates. In addition, reduce the amount of pipetting for TeSR™2 cultures, as TeSR™2 grown clumps break up easier than in mTeSR™1 and can result in undesired single cells that will die upon passage. For more information on enzymatic passaging using dispase, refer to Section 3.2.1. of the Technical Manual.

For non-enzymatic passaging, Gentle Cell Dissociation Reagent (GCDR, Catalog #07174) can be used. For more information using GCDR, refer to Section 3.2.2. of the Technical Manual.

5. Appropriate clump size for passaging
Preparation of a uniform suspension of suitable sized human ES and iPS cell clumps for passaging is critical. Clumps should be approximately 60 um 100 um in diameter (easily determined by an ocular micrometer in the microscope's eyepiece). If the clumps are too large, an increased rate of differentiation within the colonies may occur. If the clumps are too small, with many single cells present, cell survival will be compromised, decreasing the resulting number and health of colonies.

6. Plating density at time of passage
Plating density is a critical aspect of maintaining healthy human ES and iPS cells in mTeSR™1 or TeSR™2. Cultures that are either too sparsely or too densely populated can lead to differentiation. Adjust the plating density and/or split ratios to achieve a balance between having too much space between colonies and having a confluent culture. For the optimal seeding densities for different cultureware, refer to Section 5.3 of the Technical Manual.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: STEMCELL Technologies, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


STEMCELL Technologies Publishes Critical Points for Feeder-independent Cultures in mTeSR™1 or TeSR™2

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
STEMCELL Technologies Inc |
Contact: Press Office - Stemcell.com 
604-877-0713 marketing[.]stemcell.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any STEMCELL Technologies, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From STEMCELL Technologies, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  NAKIVO, Inc.

Visit  Triggr & Bloom

Visit  BizJobs.com







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today